Degradable Drug Delivery Coating - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510248651

Publication Date:

October 16, 2024

Pages:

125

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

A degradable drug delivery coating is a type of coating that is applied to medical devices, such as stents or implants, to deliver drugs over time. The coating is designed to gradually degrade or dissolve, releasing the drug into the surrounding tissue or bloodstream. The use of degradable drug delivery coatings is an important advancement in medical technology, as it allows for targeted drug delivery to specific areas of the body. The coating can be customized to release the drug at a specific rate, allowing for more precise and effective treatment.
The global market for Degradable Drug Delivery Coating was estimated to be worth US$ 208 million in 2023 and is forecast to a readjusted size of US$ 387 million by 2030 with a CAGR of 9.3% during the forecast period 2024-2030
North American market for Degradable Drug Delivery Coating was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Degradable Drug Delivery Coating was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Degradable Drug Delivery Coating was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Degradable Drug Delivery Coating include Surmodics, Hydromer, DSM Biomedical, Harland Medical Systems, Biocoat, Coatings2Go, AST Products, Surface Solutions Group and ISurTec, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Degradable Drug Delivery Coating, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Degradable Drug Delivery Coating by region & country, by Type, and by Application.
The Degradable Drug Delivery Coating market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Degradable Drug Delivery Coating.
Market Segmentation
By Company
Surmodics
Hydromer
DSM Biomedical
Harland Medical Systems
Biocoat
Coatings2Go
AST Products
Surface Solutions Group
ISurTec
AdvanSource Biomaterials
Teleflex
Argon Medical
Segment by Type:
Polymeric Coating
Hydrogel Coating
Lipid-based Coating
Protein-based Coating
Segment by Application
Drug-eluting Stents
Implants
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Degradable Drug Delivery Coating manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Degradable Drug Delivery Coating in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Degradable Drug Delivery Coating in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Degradable Drug Delivery Coating Product Introduction
1.2 Global Degradable Drug Delivery Coating Market Size Forecast
1.2.1 Global Degradable Drug Delivery Coating Sales Value (2019-2030)
1.2.2 Global Degradable Drug Delivery Coating Sales Volume (2019-2030)
1.2.3 Global Degradable Drug Delivery Coating Sales Price (2019-2030)
1.3 Degradable Drug Delivery Coating Market Trends & Drivers
1.3.1 Degradable Drug Delivery Coating Industry Trends
1.3.2 Degradable Drug Delivery Coating Market Drivers & Opportunity
1.3.3 Degradable Drug Delivery Coating Market Challenges
1.3.4 Degradable Drug Delivery Coating Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Degradable Drug Delivery Coating Players Revenue Ranking (2023)
2.2 Global Degradable Drug Delivery Coating Revenue by Company (2019-2024)
2.3 Global Degradable Drug Delivery Coating Players Sales Volume Ranking (2023)
2.4 Global Degradable Drug Delivery Coating Sales Volume by Company Players (2019-2024)
2.5 Global Degradable Drug Delivery Coating Average Price by Company (2019-2024)
2.6 Key Manufacturers Degradable Drug Delivery Coating Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Degradable Drug Delivery Coating Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Degradable Drug Delivery Coating
2.9 Degradable Drug Delivery Coating Market Competitive Analysis
2.9.1 Degradable Drug Delivery Coating Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Degradable Drug Delivery Coating Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Degradable Drug Delivery Coating as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Polymeric Coating
3.1.2 Hydrogel Coating
3.1.3 Lipid-based Coating
3.1.4 Protein-based Coating
3.2 Global Degradable Drug Delivery Coating Sales Value by Type
3.2.1 Global Degradable Drug Delivery Coating Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Degradable Drug Delivery Coating Sales Value, by Type (2019-2030)
3.2.3 Global Degradable Drug Delivery Coating Sales Value, by Type (%) (2019-2030)
3.3 Global Degradable Drug Delivery Coating Sales Volume by Type
3.3.1 Global Degradable Drug Delivery Coating Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Degradable Drug Delivery Coating Sales Volume, by Type (2019-2030)
3.3.3 Global Degradable Drug Delivery Coating Sales Volume, by Type (%) (2019-2030)
3.4 Global Degradable Drug Delivery Coating Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Drug-eluting Stents
4.1.2 Implants
4.1.3 Others
4.2 Global Degradable Drug Delivery Coating Sales Value by Application
4.2.1 Global Degradable Drug Delivery Coating Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Degradable Drug Delivery Coating Sales Value, by Application (2019-2030)
4.2.3 Global Degradable Drug Delivery Coating Sales Value, by Application (%) (2019-2030)
4.3 Global Degradable Drug Delivery Coating Sales Volume by Application
4.3.1 Global Degradable Drug Delivery Coating Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Degradable Drug Delivery Coating Sales Volume, by Application (2019-2030)
4.3.3 Global Degradable Drug Delivery Coating Sales Volume, by Application (%) (2019-2030)
4.4 Global Degradable Drug Delivery Coating Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Degradable Drug Delivery Coating Sales Value by Region
5.1.1 Global Degradable Drug Delivery Coating Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Degradable Drug Delivery Coating Sales Value by Region (2019-2024)
5.1.3 Global Degradable Drug Delivery Coating Sales Value by Region (2025-2030)
5.1.4 Global Degradable Drug Delivery Coating Sales Value by Region (%), (2019-2030)
5.2 Global Degradable Drug Delivery Coating Sales Volume by Region
5.2.1 Global Degradable Drug Delivery Coating Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Degradable Drug Delivery Coating Sales Volume by Region (2019-2024)
5.2.3 Global Degradable Drug Delivery Coating Sales Volume by Region (2025-2030)
5.2.4 Global Degradable Drug Delivery Coating Sales Volume by Region (%), (2019-2030)
5.3 Global Degradable Drug Delivery Coating Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Degradable Drug Delivery Coating Sales Value, 2019-2030
5.4.2 North America Degradable Drug Delivery Coating Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Degradable Drug Delivery Coating Sales Value, 2019-2030
5.5.2 Europe Degradable Drug Delivery Coating Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Degradable Drug Delivery Coating Sales Value, 2019-2030
5.6.2 Asia Pacific Degradable Drug Delivery Coating Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Degradable Drug Delivery Coating Sales Value, 2019-2030
5.7.2 South America Degradable Drug Delivery Coating Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Degradable Drug Delivery Coating Sales Value, 2019-2030
5.8.2 Middle East & Africa Degradable Drug Delivery Coating Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Degradable Drug Delivery Coating Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Degradable Drug Delivery Coating Sales Value
6.2.1 Key Countries/Regions Degradable Drug Delivery Coating Sales Value, 2019-2030
6.2.2 Key Countries/Regions Degradable Drug Delivery Coating Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Degradable Drug Delivery Coating Sales Value, 2019-2030
6.3.2 United States Degradable Drug Delivery Coating Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Degradable Drug Delivery Coating Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Degradable Drug Delivery Coating Sales Value, 2019-2030
6.4.2 Europe Degradable Drug Delivery Coating Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Degradable Drug Delivery Coating Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Degradable Drug Delivery Coating Sales Value, 2019-2030
6.5.2 China Degradable Drug Delivery Coating Sales Value by Type (%), 2023 VS 2030
6.5.3 China Degradable Drug Delivery Coating Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Degradable Drug Delivery Coating Sales Value, 2019-2030
6.6.2 Japan Degradable Drug Delivery Coating Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Degradable Drug Delivery Coating Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Degradable Drug Delivery Coating Sales Value, 2019-2030
6.7.2 South Korea Degradable Drug Delivery Coating Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Degradable Drug Delivery Coating Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Degradable Drug Delivery Coating Sales Value, 2019-2030
6.8.2 Southeast Asia Degradable Drug Delivery Coating Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Degradable Drug Delivery Coating Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Degradable Drug Delivery Coating Sales Value, 2019-2030
6.9.2 India Degradable Drug Delivery Coating Sales Value by Type (%), 2023 VS 2030
6.9.3 India Degradable Drug Delivery Coating Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Surmodics
7.1.1 Surmodics Company Information
7.1.2 Surmodics Introduction and Business Overview
7.1.3 Surmodics Degradable Drug Delivery Coating Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Surmodics Degradable Drug Delivery Coating Product Offerings
7.1.5 Surmodics Recent Development
7.2 Hydromer
7.2.1 Hydromer Company Information
7.2.2 Hydromer Introduction and Business Overview
7.2.3 Hydromer Degradable Drug Delivery Coating Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Hydromer Degradable Drug Delivery Coating Product Offerings
7.2.5 Hydromer Recent Development
7.3 DSM Biomedical
7.3.1 DSM Biomedical Company Information
7.3.2 DSM Biomedical Introduction and Business Overview
7.3.3 DSM Biomedical Degradable Drug Delivery Coating Sales, Revenue and Gross Margin (2019-2024)
7.3.4 DSM Biomedical Degradable Drug Delivery Coating Product Offerings
7.3.5 DSM Biomedical Recent Development
7.4 Harland Medical Systems
7.4.1 Harland Medical Systems Company Information
7.4.2 Harland Medical Systems Introduction and Business Overview
7.4.3 Harland Medical Systems Degradable Drug Delivery Coating Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Harland Medical Systems Degradable Drug Delivery Coating Product Offerings
7.4.5 Harland Medical Systems Recent Development
7.5 Biocoat
7.5.1 Biocoat Company Information
7.5.2 Biocoat Introduction and Business Overview
7.5.3 Biocoat Degradable Drug Delivery Coating Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Biocoat Degradable Drug Delivery Coating Product Offerings
7.5.5 Biocoat Recent Development
7.6 Coatings2Go
7.6.1 Coatings2Go Company Information
7.6.2 Coatings2Go Introduction and Business Overview
7.6.3 Coatings2Go Degradable Drug Delivery Coating Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Coatings2Go Degradable Drug Delivery Coating Product Offerings
7.6.5 Coatings2Go Recent Development
7.7 AST Products
7.7.1 AST Products Company Information
7.7.2 AST Products Introduction and Business Overview
7.7.3 AST Products Degradable Drug Delivery Coating Sales, Revenue and Gross Margin (2019-2024)
7.7.4 AST Products Degradable Drug Delivery Coating Product Offerings
7.7.5 AST Products Recent Development
7.8 Surface Solutions Group
7.8.1 Surface Solutions Group Company Information
7.8.2 Surface Solutions Group Introduction and Business Overview
7.8.3 Surface Solutions Group Degradable Drug Delivery Coating Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Surface Solutions Group Degradable Drug Delivery Coating Product Offerings
7.8.5 Surface Solutions Group Recent Development
7.9 ISurTec
7.9.1 ISurTec Company Information
7.9.2 ISurTec Introduction and Business Overview
7.9.3 ISurTec Degradable Drug Delivery Coating Sales, Revenue and Gross Margin (2019-2024)
7.9.4 ISurTec Degradable Drug Delivery Coating Product Offerings
7.9.5 ISurTec Recent Development
7.10 AdvanSource Biomaterials
7.10.1 AdvanSource Biomaterials Company Information
7.10.2 AdvanSource Biomaterials Introduction and Business Overview
7.10.3 AdvanSource Biomaterials Degradable Drug Delivery Coating Sales, Revenue and Gross Margin (2019-2024)
7.10.4 AdvanSource Biomaterials Degradable Drug Delivery Coating Product Offerings
7.10.5 AdvanSource Biomaterials Recent Development
7.11 Teleflex
7.11.1 Teleflex Company Information
7.11.2 Teleflex Introduction and Business Overview
7.11.3 Teleflex Degradable Drug Delivery Coating Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Teleflex Degradable Drug Delivery Coating Product Offerings
7.11.5 Teleflex Recent Development
7.12 Argon Medical
7.12.1 Argon Medical Company Information
7.12.2 Argon Medical Introduction and Business Overview
7.12.3 Argon Medical Degradable Drug Delivery Coating Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Argon Medical Degradable Drug Delivery Coating Product Offerings
7.12.5 Argon Medical Recent Development
8 Industry Chain Analysis
8.1 Degradable Drug Delivery Coating Industrial Chain
8.2 Degradable Drug Delivery Coating Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Degradable Drug Delivery Coating Sales Model
8.5.2 Sales Channel
8.5.3 Degradable Drug Delivery Coating Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Surmodics
Hydromer
DSM Biomedical
Harland Medical Systems
Biocoat
Coatings2Go
AST Products
Surface Solutions Group
ISurTec
AdvanSource Biomaterials
Teleflex
Argon Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂